MIKAJAKI

MIKAJAKI SA is a Swiss medtech company established in April 2018, aiming to address the worldwide shortage of eye care professionals and increasing patient demand. The company was co-founded by Dr. Michael Assouline, an ophthalmologist, and Jacky Hochner, who serves as CEO. Their combined experience in surgical practice and ophthalmic device commercialization informed the development of their core product. Supported by investors like Blueocean Ventures and institutions such as Innosuisse and the FONGIT Innovation Incubator, the Geneva-based firm has developed a fully automated, multi-patient ocular diagnostics platform.

The company's flagship product is the EyeLib™, a robotic station designed to automate and streamline the eye examination process. This platform is a direct response to the growing gap between the number of patients needing eye care and the limited availability of ophthalmologists and optometrists. The system integrates robotics, digital technology, and artificial intelligence to perform a comprehensive eye health checkup. A patient begins by interacting with a virtual agent, Ariane-Insight™, to report their medical history and current symptoms. Following this, the EyeLib™ station conducts a 3D full-body scan to adjust for the patient's morphology, ensuring accessibility for various body types, including wheelchair users. In under six minutes, the device performs approximately 100 different measurements and automates around twenty diagnostic tests, covering conditions like cataracts, glaucoma, and myopia.

The data collected from the virtual agent and the physical scan are synthesized into a single "SmartVision Report™". This report uses proprietary AI algorithms to provide a detailed pre-diagnosis, optical prescriptions, and imaging of the eye's structures for the healthcare professional. This process enhances operating efficiency for clinics by optimizing patient flow, reducing waiting times, and lowering costs. MIKAJAKI's business model targets hospital clinics and ophthalmology centers, offering the EyeLib™ system at a cost significantly lower than traditional diagnostic equipment setups. The company generates revenue through a fixed-price-per-use model or comprehensive service packages that include installation, training, and maintenance.

Significant milestones for MIKAJAKI include obtaining the CE mark for EyeLib™ in September 2020, allowing for its commercial rollout in Europe. The company also secured ISO 13485:2016 certification for its quality management system in April 2021. MIKAJAKI has actively partnered with engineering group SEGULA Technologies for the industrialization of the EyeLib™ platform and has installed initial units in specialist centers in France. The company was named one of the top 50 Swiss startups to invest in by Bilan magazine in 2020 and continues to garner awards for its approach to ophthalmic diagnostics.

Keywords: ophthalmic diagnostics, robotic eye exam, automated eye care, EyeLib, medical robotics, ophthalmology AI, patient triage, telehealth ophthalmology, ocular health platform, Michael Assouline, Jacky Hochner, digital eye health, glaucoma detection, cataract screening, myopia analysis, SmartVision Report, Ariane-Insight, medtech, eye care efficiency, automated refractometry